<code id='7E05F00536'></code><style id='7E05F00536'></style>
    • <acronym id='7E05F00536'></acronym>
      <center id='7E05F00536'><center id='7E05F00536'><tfoot id='7E05F00536'></tfoot></center><abbr id='7E05F00536'><dir id='7E05F00536'><tfoot id='7E05F00536'></tfoot><noframes id='7E05F00536'>

    • <optgroup id='7E05F00536'><strike id='7E05F00536'><sup id='7E05F00536'></sup></strike><code id='7E05F00536'></code></optgroup>
        1. <b id='7E05F00536'><label id='7E05F00536'><select id='7E05F00536'><dt id='7E05F00536'><span id='7E05F00536'></span></dt></select></label></b><u id='7E05F00536'></u>
          <i id='7E05F00536'><strike id='7E05F00536'><tt id='7E05F00536'><pre id='7E05F00536'></pre></tt></strike></i>

          hotspot

          hotspot

          author:focus    Page View:5
          Merck
          Kena Betancur/Getty Images

          MADRID — Merck is paying billions of dollars to partner with Daiichi Sankyo on a series of cancer drugs, underscoring the excitement around targeted chemotherapy treatments. 

          The deal includes a $4 billion upfront payment and an additional $1.5 billion over the next two years. Up to $16.5 billion more is on the table depending on the success of the drugs in development. 

          advertisement

          The announcement on Thursday night in the United States came on the eve of one the cancer field’s biggest annual conferences, the European Society for Medical Oncology Congress, being held this year in Madrid. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          Health Care Service Corp to buy Cigna Medicare Advantage plans
          Health Care Service Corp to buy Cigna Medicare Advantage plans

          CignaisofficiallyexitingtheMedicarebusiness,agreeingtosellallofitsMedicareinsuranceplanstoHealthCare

          read more
          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more

          Boston competes with Raleigh

          PatGreenhouse/GlobeStaffMORRISVILLE,N.C.—TenminutesfromtheRaleighairport,thefutureofbiotechisunderco